We are live on
!
Find out more
AAM
AR Asset Management Portfolio holdings
AUM
$546M
Turnover
5.65%
1-Year Est. Return
24.08%
This Fund
S&P 500
This Quarter
Est. Return
+11.81%
1 Year Est. Return
+24.08%
3 Year Est. Return
+64.88%
5 Year Est. Return
+92.85%
10 Year Est. Return
+260.28%
AUM
$394M
AUM Growth
+$36.8M
(+10%)
Cap. Flow
-$1.71M
Cap. Flow
% of AUM
-0.43%
Top 10 Holdings %
Top 10 Hldgs %
39.41%
Holding
121
New
2
Increased
3
Reduced
11
Closed
5
Avg Time Held
6.1
years
Top 10 Avg Time Held
5.4
years
Top 20 Avg Time Held
5.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Organon & Co
OGN
|
+$2.84M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
+$872K |
| 3 |
Church & Dwight Co
CHD
|
+$218K |
| 4 |
Amazon
AMZN
|
+$3.42K |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.66K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$1.97M |
| 2 |
Verizon
VZ
|
+$1.73M |
| 3 |
Marker Therapeutics
MRKR
|
+$276K |
| 4 |
Vimeo
VMEO
|
+$235K |
| 5 |
Viatris
VTRS
|
+$233K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 22.72% |
| 2 | Technology | 17.29% |
| 3 | Healthcare | 13.63% |
| 4 | Financials | 12.11% |
| 5 | Consumer Discretionary | 8.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.01T
| $53M | 13.46% |
298,673
-967
| -0.3% | -$153K |
2013 Q2
34 quarters
|
|
2
Chevron
CVX
$436B
| $13.5M | 3.44% |
115,326
| – | – |
2013 Q2
34 quarters
|
|
3
Nike
NKE
$52.4B
| $12.6M | 3.19% |
75,325
| – | – |
2013 Q2
34 quarters
|
|
4
Procter & Gamble
PG
$364B
| $12.2M | 3.11% |
74,834
| – | – |
2013 Q2
34 quarters
|
|
5
Target
TGT
$70.6B
| $11.9M | 3.01% |
51,220
| – | – |
2013 Q2
34 quarters
|
|
6
JPMorgan Chase
JPM
$890B
| $10.8M | 2.73% |
68,031
-200
| -0.3% | -$32.8K |
2013 Q2
34 quarters
|
|
7
Philip Morris
PM
$320B
| $10.7M | 2.71% |
112,406
| – | – |
2013 Q2
34 quarters
|
|
8
Coca-Cola
KO
$395B
| $10.4M | 2.63% |
174,980
| – | – |
2013 Q2
34 quarters
|
|
9
Merck
MRK
$364B
| $10.3M | 2.62% |
134,570
| – | – |
2013 Q2
34 quarters
|
|
10
Diageo
DEO
$51.2B
| $9.91M | 2.52% |
45,040
| – | – |
2013 Q2
34 quarters
|
|
11
Pfizer
PFE
$166B
| $8.36M | 2.12% |
141,575
| – | – |
2013 Q2
34 quarters
|
|
12
Alphabet (Google) Class C
GOOG
$4.2T
| $8.3M | 2.11% |
57,400
| – | – |
2016 Q2
22 quarters
|
|
13
Zoetis
ZTS
$31.1B
| $8.27M | 2.1% |
33,900
| – | – |
2013 Q2
34 quarters
|
|
14
Home Depot
HD
$295B
| $8.11M | 2.06% |
19,550
| – | – |
2013 Q2
34 quarters
|
|
15
Berkshire Hathaway Class A
BRK.A
$1.13T
| $8.11M | 2.06% |
18
| – | – |
2013 Q2
34 quarters
|
|
16
Walt Disney
DIS
$188B
| $7.51M | 1.91% |
48,465
-64
| -0.1% | -$10.3K |
2013 Q2
34 quarters
|
|
17
PepsiCo
PEP
$176B
| $7.3M | 1.85% |
42,009
| – | – |
2013 Q2
34 quarters
|
|
18
Iron Mountain
IRM
$33B
| $6.89M | 1.75% |
131,600
| – | – |
2020 Q1
7 quarters
|
|
19
Johnson & Johnson
JNJ
$612B
| $6.62M | 1.68% |
38,690
| – | – |
2013 Q2
34 quarters
|
|
20
General Motors
GM
$72.9B
| $6.62M | 1.68% |
112,840
| – | – |
2013 Q2
34 quarters
|
|
21
Berkshire Hathaway Class B
BRK.B
$1.13T
| $6.13M | 1.56% |
20,518
| – | – |
2013 Q2
34 quarters
|
|
22
AbbVie
ABBV
$501B
| $5.89M | 1.5% |
43,500
| – | – |
2013 Q2
34 quarters
|
|
23
Microsoft
MSFT
$3.96T
| $5.3M | 1.34% |
15,750
| – | – |
2013 Q2
34 quarters
|
|
24
Bank of Hawaii
BOH
$2.6B
| $5.15M | 1.31% |
61,500
| – | – |
2013 Q2
34 quarters
|
|
25
Altria Group
MO
$122B
| $4.9M | 1.24% |
103,326
| – | – |
2013 Q2
34 quarters
|
|
Similar funds
QAM
LF
SCM
TGAM
HW
UFF
DBG
TI
AR Asset Management's Q4 2021 Portfolio in Review
As of Q4 2021, AR Asset Management held 121 positions worth $394M, up 10% from $357M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
AR Asset Management's Q4 2021 filing shows 2 new, 3 increased, 11 reduced and 5 closed positions. Its largest new stake was Prometheus Biosciences, Inc. Common Stock: 27,857 shares worth $1.1M. The largest sale was AT&T, an estimated $1.97M.
By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, down from 23% a quarter earlier, followed by Technology and Healthcare.
- AR Asset Management's largest Q4 2021 buy was Prometheus Biosciences, Inc. Common Stock: 27,857 shares worth $1.1M.
- AR Asset Management added most to Organon & Co in Q4 2021, an estimated $2.84M increase.
- AR Asset Management's biggest Q4 2021 reduction was Verizon, cutting an estimated $1.73M.
- AR Asset Management fully exited AT&T in Q4 2021, selling an estimated $1.97M.
- AR Asset Management's ten largest holdings make up 39% of its $394M portfolio in Q4 2021.
- AR Asset Management opened 2 new positions and closed 5 in Q4 2021.
- AR Asset Management's portfolio value rose 10% quarter-over-quarter to $394M.
Based on AR Asset Management's 13F filing for Q4 2021, filed 7 Feb 2022.